Search Results - "Chan, Marieta"
-
1
Defining the structural basis for human leukocyte antigen reactivity in clinical transplantation
Published in Scientific reports (27-10-2020)“…The current state-of-the-art technology employed to assess anti-human leukocyte antigen antibodies (Anti-HLA Ab) for donor-recipient matching and patient risk…”
Get full text
Journal Article -
2
153-P: A study of HLA class I antigen and class II allele frequencies in Singapore Chinese and Malay renal patients
Published in Human immunology (01-10-2007)Get full text
Journal Article -
3
A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection
Published in Cytotherapy (Oxford, England) (01-10-2024)“…Post-transplant or hematological cancer patients have a higher risk of mortality after infection with ancestral and early variants of severe acute respiratory…”
Get full text
Journal Article -
4
Prevalence of HLA antibodies in female blood donors in Singapore
Published in Human immunology (01-10-2015)“…Aim Antibodies against the human leukocyte antigen (HLA) in donors’ blood are implicated in the development of transfusion-related acute lung injury (TRALI)…”
Get full text
Journal Article -
5
Unrepresented human leucocyte antigen alleles in single‐antigen bead assays: A single‐centre cohort study
Published in International journal of immunogenetics (01-12-2023)“…Human leucocyte antigen (HLA) alleles may generate antibodies that are undetectable by routine single‐antigen beads (SABs) assays if their unique epitopes are…”
Get full text
Journal Article -
6
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
Published in Cancer Immunology, Immunotherapy (01-06-2022)“…Introduction Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC), and provides a target for a dendritic cell (DC) vaccine. CD137 ligand…”
Get full text
Journal Article -
7
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC)
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 6535 Background: Epstein-Barr virus (EBV) is associated with non-keratinising (NK) NPC, a disease prevalent in Southeast Asia, and provides a…”
Get full text
Journal Article -
8
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission
Published in Cytotherapy (Oxford, England) (01-08-2012)“…Abstract Background aims Cytokine-induced killer (CIK) cells have shown remarkable cytotoxicity against various tumors in vitro and in animal studies. We…”
Get full text
Journal Article -
9
Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy
Published in Experimental hematology (01-09-2011)“…Objective In our clinical studies involving cytokine-induced killer (CIK) cells for patients with hematological malignancies, starting cells came from a…”
Get full text
Journal Article -
10
Large-scale Isolation of Highly Pure "Untouched" Regulatory T Cells in a GMP Environment for Adoptive Cell Therapy
Published in Journal of immunotherapy (1997) (01-07-2015)“…Adoptive cell therapy is an emerging treatment strategy for a number of serious diseases. Regulatory T (Treg) cells represent 1 cell type of particular…”
Get full text
Journal Article -
11
Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication
Published in PLoS medicine (01-07-2005)“…Hepatitis B virus (HBV) infection results in complications such as cirrhosis and hepatocellular carcinoma. Suppressing viral replication in chronic HBV…”
Get full text
Journal Article -
12
Human leukocyte antigen allele and haplotype frequencies in Singapore bone marrow donors and cord blood units
Published in Blood cell therapy (25-11-2022)“…We describe the allele and haplotype frequencies seen in a volunteer unrelated bone marrow donor registry, a public cord blood bank, and donor/recipient…”
Get full text
Journal Article -
13
Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication
Published in PLoS medicine (01-07-2005)“…BackgroundHepatitis B virus (HBV) infection results in complications such as cirrhosis and hepatocellular carcinoma. Suppressing viral replication in chronic…”
Get full text
Journal Article